Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$42.05 - $47.77 $33,640 - $38,216
-800 Reduced 7.56%
9,782 $426,000
Q1 2022

May 12, 2022

SELL
$40.23 - $47.74 $19,350 - $22,962
-481 Reduced 4.35%
10,582 $461,000
Q4 2021

Feb 08, 2022

BUY
$38.88 - $45.31 $21,034 - $24,512
541 Added 5.14%
11,063 $488,000
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $1,590 - $1,769
-41 Reduced 0.39%
10,522 $402,000
Q2 2021

Aug 10, 2021

BUY
$36.52 - $41.46 $50,397 - $57,214
1,380 Added 15.03%
10,563 $421,000
Q1 2021

May 14, 2021

BUY
$34.27 - $40.01 $959 - $1,120
28 Added 0.31%
9,183 $328,000
Q4 2020

Feb 16, 2021

SELL
$34.07 - $39.94 $84,561 - $99,131
-2,482 Reduced 21.33%
9,155 $337,000
Q3 2020

Nov 12, 2020

BUY
$38.11 - $42.99 $76,944 - $86,796
2,019 Added 20.99%
11,637 $438,000
Q2 2020

Aug 10, 2020

SELL
$37.87 - $43.58 $42,149 - $48,504
-1,113 Reduced 10.37%
9,618 $392,000
Q1 2020

May 15, 2020

BUY
$32.47 - $48.83 $100,169 - $150,640
3,085 Added 40.35%
10,731 $407,000
Q4 2019

Feb 07, 2020

SELL
$42.0 - $48.25 $106,050 - $121,831
-2,525 Reduced 24.83%
7,646 $359,000
Q3 2019

Nov 07, 2019

SELL
$40.46 - $43.52 $49,482 - $53,224
-1,223 Reduced 10.73%
10,171 $434,000
Q2 2019

Aug 15, 2019

BUY
$39.4 - $42.7 $197 - $213
5 Added 0.04%
11,394 $456,000
Q1 2019

May 07, 2019

BUY
$38.57 - $42.69 $51,876 - $57,418
1,345 Added 13.39%
11,389 $476,000
Q4 2018

Feb 15, 2019

SELL
$37.8 - $42.69 $97,032 - $109,585
-2,567 Reduced 20.36%
10,044 $384,000
Q3 2018

Nov 15, 2018

BUY
$39.75 - $42.69 $12,243 - $13,148
308 Added 2.5%
12,611 $507,000
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $87,419 - $94,371
2,207 Added 21.86%
12,303 $496,000
Q1 2018

May 14, 2018

SELL
$36.18 - $40.15 $85,059 - $94,392
-2,351 Reduced 18.89%
10,096 $394,000
Q4 2017

Feb 09, 2018

BUY
$35.34 - $41.9 $16,433 - $19,483
465 Added 3.88%
12,447 $442,000
Q3 2017

Nov 02, 2017

BUY
$39.44 - $41.55 $472,570 - $497,852
11,982
11,982 $486,000

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Smith, Moore & Co. Portfolio

Follow Smith, Moore & Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.